Ascendis Pharma A/S (ASND) has an average rating of buy and mean price target of $311.82, according to analysts polled by FactSet.
What else is happening in Research?
Research
Macquarie Initiates Pursuit Attractions and Hospitality With Outperform Rating, $62 Price Target
Pursuit Attractions and Hospitality (PRSU) has an average rating of buy and mean price target of $61.80, according to analysts polled by FactSet.Price: $48.66, Change: $+0.11, Percent Change: +0.23%
$PRSU
Research
UBS Downgrades First Citizens BancShares to Neutral From Buy, Adjusts PT to $2,250 From $2,325
First Citizens BancShares (FCNCA) has an average rating of hold and mean price target of $2,324.08, according to analysts polled by FactSet.Price: $2175.51, Change: $+2.51, Percent Change: +0.12%
$FCNCA
Research
Arqaam Capital Reduces Catrion Catering's PT, Affirms Buy Rating
Arqaam Capital on Monday lowered the price target for airlines-focused catering company Catrion Catering (SASE:6004) to 90.00 Saudi riyals from 112.00 riyals and kept its rating at buy.
SASE:6004